Restructuring Charges
Johnson & Johnson Restructuring Charges decreased by 61.9% to $32.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 88.2%, from $17.00M to $32.00M. Over 4 years (FY 2021 to FY 2025), Restructuring Charges shows relatively stable performance with a -2.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
Frequent or large charges may indicate operational instability or a need for significant strategic pivots, while occasional charges are standard in large-scale transformations.
Detailed definition
Restructuring charges are one-time costs associated with reorganizing a company's operations, such as severance pay, fac...
Peer comparison
Used by analysts to identify non-recurring items that distort year-over-year operating comparisons.
restructuring_chargesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $56.00M | $60.00M | $83.00M | $70.00M | $85.00M | $82.00M | $84.00M | $130.00M | $145.00M | $158.00M | $56.00M | $164.00M | -$13.00M | $41.00M | $42.00M | $17.00M | $64.00M | $63.00M | $84.00M | $32.00M |
| QoQ Change | — | +7.1% | +38.3% | -15.7% | +21.4% | -3.5% | +2.4% | +54.8% | +11.5% | +9.0% | -64.6% | +192.9% | -107.9% | +415.4% | +2.4% | -59.5% | +276.5% | -1.6% | +33.3% | -61.9% |
| YoY Change | — | — | — | — | +51.8% | +36.7% | +1.2% | +85.7% | +70.6% | +92.7% | -33.3% | +26.2% | -109.0% | -74.1% | -25.0% | -89.6% | +592.3% | +53.7% | +100.0% | +88.2% |
Business Segments
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Medical Devices | $100.00M | $28.00M | $45.00M | $100.00M | $100.00M | $200.00M | $100.00M | $100.00M |
| Innovative Medicine | -$63.00M | $19.00M | $2.00M | $100.00M | $0.00 | $0.00 | -$100.00M | — |
| Total | -$13.00M | $41.00M | $42.00M | $17.00M | $64.00M | $63.00M | $84.00M | $32.00M |
Medtech Ortho Franchise, Orthopaedics Restructuring Plan are derived from annual filings.
Innovative Medicine, Pharmaceutical were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
Restructuring Charges at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's restructuring charges?
- Johnson & Johnson (JNJ) reported restructuring charges of $32.00M in Q1 2026.
- How has Johnson & Johnson's restructuring charges changed year-over-year?
- Johnson & Johnson's restructuring charges increased by 88.2% year-over-year, from $17.00M to $32.00M.
- What is the long-term trend for Johnson & Johnson's restructuring charges?
- Over 4 years (2021 to 2025), Johnson & Johnson's restructuring charges has grown at a -2.5% compound annual growth rate (CAGR), from $252.00M to $228.00M.
- What does restructuring charges mean?
- One-time costs related to reorganizing or downsizing business operations.